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Abstract
Background: While psychological factors may play a significant role in the development and course of asthma, the
availability of information on the scale of the problem and the factors associated with psychogenic asthma is limited. The
aim of the study was to assess the frequency of coexistence of asthma and other diseases considered to be of psychoso-
matic origin, to assess the impact of stress and strong emotions on the occurrence of acute exacerbations of asthma, to
measure the level of alexithymia in asthmatic patients, and to look for its association with acute exacerbations triggered by
stress and strong emotions. The level of alexithymia was also assessed in the context of asthma control.
Materials and methods: The study was conducted on a group of 54 patients (75.9% females) with a diagnosis of asthma
(mean age: 54.37±14.52 years) at the Independent Public Central Teaching Hospital in Warsaw, Poland. The patients
completed a questionnaire composed of the Asthma Control Test, a list of factors that could trigger an acute exacerbation of
asthma, and the Toronto Alexithymia Scale (TAS-26; translated into Polish by E. Scigala and T. Maruszewski). The patients
were also asked about any co-morbidities that had been diagnosed by other doctors and that might be caused, at least in
part, by psychological and behavioural factors, and co-morbidities that might be associated with stress but are character-
ised by somatic manifestations. The co-morbidities in question were: irritable bowel syndrome, atopic dermatitis, depres-
sion, panic disorder, and anorexia nervosa. In the remainder of this paper these disorders are collectively referred to as
‘psychosomatic disorders’. The statistical analysis was performed using SPSS 14.0 PL at the significance level p<0.05.
Non-parametric tests for independent samples were used to test the associations between the qualitative variables.
Results: In 50% of the cases, at least one of the following disease entities were identified in the patients carrying the
diagnosis of asthma: irritable bowel syndrome (n = 8), atopic dermatitis (n = 7), depression (n = 13), panic disorder (n =
9). Alexithymia was diagnosed in 11 cases (21.6%). The correlation of the level of alexithymia with stress and strong
emotions was statistically non-significant (c2 = 0.106, p > 0.05). Stress and/or strong emotions were identified as factors
triggering acute exacerbations of asthma in 33 cases (61.1%). Poor, good, and complete asthma control was confirmed in
72.5%, 17.6% and 9.8% of the cases, respectively. No association of asthma control with the occurrence of alexithymia was
identified (c2 = 0.358, p > 0.05). No association of asthma control with gender was identified (c2 = 0.605, p > 0.05).
Conclusions: The high level of alexithymia in asthmatic patients, the frequent occurrence of disorders considered to be
psychosomatic in origin, and the considerable impact of stress and strong emotions on the development of acute
exacerbations of the disease confirm that asthma can be considered a psychosomatic disorder.
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Introduction
Asthma: somatic and psychogenic aetiologies
Asthma has long been a focus of psychosoma-
tics. Two currents emerged over the years: one as-
sumed a psychogenic aetiology of asthma, while
the other focussed on elucidating the biological
basis of the disease [1]. Researchers are currently
trying to explain the association of emotional sta-
tes with asthma based on a model in which stress
and negative emotions activate the immune sys-
tem and increase the activity of inflammatory mar-
kers in the blood [2], which may in turn cause de-
pression, somnolence [3], social withdrawal, and
lack of appetite [4]. A relationship has been shown
between the manifestation of asthma and the acti-
vation of the insula and the anterior cingulate gy-
rus—central nervous system areas responsible,
among other things, for emotions and cognitive
processes [5].
According to the Global Initiative for Asthma
(GINA), asthma is defined as a chronic inflamma-
tory disorder of the airways associated with bron-
chial hyperresponsiveness, leading to recurrent
episodes of wheezing, breathlessness, chest tight-
ness, and coughing, particularly at night or in the
early morning [6]. These episodes are usually as-
sociated with an impaired airflow through constric-
ted bronchi, an impairment which often subsides
with treatment. Factors contributing to the deve-
lopment of asthma include: genetic factors, obesi-
ty, male sex, and environmental factors (allergens,
respiratory tract infections, occupational factors,
tobacco smoke, environmental pollution, diet).
According to the GINA guidelines, emotional stress
is not regarded as a factor causing asthma, altho-
ugh it is considered a factor that exacerbates the
course of the disease [6]. On the other hand, ac-
cording to the 10th edition of the International Sta-
tistical Classification of Diseases and Related He-
alth Problems (ICD-10), in selected cases, asthma
may be coded as J45+F54, making it possible to
indicate the presence of psychological and beha-
vioural factors, which may play the main role in
the aetiology of a somatic disorder [7].
The problem of alexithymia
A psychological factor that may cause or exa-
cerbate asthma is a syndrome referred to as alexi-
thymia. Alexithymia is a construct which takes
into account regulation of emotions and persona-
lity changes in the pathogenesis of multiple soma-
tic diseases [8]. According to the simplest defini-
tion, alexithymia is the inability to understand and
identify emotions and to describe emotions with
words and express them [9]. The overwhelming
majority of researchers believe that alexithymia has
the following components:
— difficulty identifying and describing feelings;
— difficulty distinguishing between feelings and
emotional arousal;
— limited ability to fantasise;
— tendency towards describing situations asso-
ciated with emotions in a very detailed man-
ner (operational thinking).
Studies have shown that alexithymics find it
very difficult to describe their own emotional sta-
tes. The matter is not so straightforward, however,
when it comes to describing other people’s emo-
tions. Alexithymics find it more difficult to iden-
tify complex emotions in other people and inter-
pret symbolic emotions from images or films com-
pared to non-alexithymics. They are, however, able
to describe the feeling and expression of simple
emotions in other people as accurately as non-ale-
xithymics [10]. In addition, in typical situations,
in which “patterns” of feeling emotions exist, ale-
xithymics function in the same way as people wi-
thout an increased level of alexithymia. The syn-
drome is also associated with a lack of emotional
expression (gestures, smiles, facial expression) and
a lack of well-developed emotional regulatory
mechanisms. The lack of healthy emotional regu-
latory mechanisms leads to frequent use of prima-
ry (non-adaptive) defence mechanisms, such as
projection or denial [10]. Considerable differences
of opinion exist as regards the genesis of alexithy-
mia. Researchers representing the psychoanalyti-
cal approach point to the influence of early chil-
dhood experiences with particular emphasis on the
mother-child relationship. Representatives of the
cognitive approach seek the causes of alexithymia
in post-traumatic stress disorder and introduce a
dual definition of the syndrome: alexithymia as a
permanent personality trait and alexithymia as a
condition which may be caused by extremely
stressful situations [11]. As we do not know the
direction of association between alexithymia and
psychosomatic disorders we should assume that
alexithymia might be one of the risk factors of psy-
chosomatic disorders. It might also develop as a
consequence of a sudden deterioration of health
(as a coping method); it is also possible that both
of these circumstances affect its development [10].
The psyche and the soma, or the association
of alexithymia with asthma and other dis-
ease entities
The list of diseases considered psychosoma-
tic in origin started to be formed over 2000 years
Alicja Moes-Wójtowicz et al., Asthma as a psychosomatic disorder
15www.pneumonologia.viamedica.pl
ago by Greek philosophers [12]. The best-known
list was drawn up by Franz Alexander in 1952.
Based on his own studies and observations, he in-
cluded the following diseases in the list of psycho-
somatic disorders: asthma, peptic ulcer disease,
ulcerating colitis, atopic dermatitis, rheumatoid
arthritis, hypertension, and hyperthyroidism [13].
At present, given the progress in medicine, the
causes of these conditions are sought in genetic and
environmental factors rather than psychosomatic
abnormalities. On the other hand, ICD-10 accepts
recognising psychological and behavioural factors
as being of key importance in the aetiology of so-
matic disorders (F54 according to ICD-10), and
recognises manifestations such as cough, diarrho-
ea, dyspepsia, irritable bowel syndrome, hyperven-
tilation, and others as vegetative abnormalities that
are not manifestations of a somatic disease of an
organ or a whole system (F45.3 according to ICD-
10) [7]. Taking into account both these opinions,
each disease should be treated as a combination
of genetic, environmental, psychological, and be-
havioural factors, and the significance of each of
these factors should be assessed separately. In or-
der to do that, standardised tools are necessary:
questionnaires for the assessment of the level of
alexithymia in this case. Table 1 reviews studies
investigating the prevalence of alexithymia and
conditions considered psychosomatic [11, 14–17].
Data on asthma vary. In patients with an asth-
ma episode requiring hospitalisation, alexithymia
was significantly more common (24%) compared
with patients who did not require hospitalisation
(12%) and healthy individuals (12%) [18]. In ano-
ther study of 25 patients with asthma, an elevated
level of alexithymia was observed in 12% of the
patients. These results do not differ significantly
from those obtained for the general population, in
which the prevalence of alexithymia ranges from
8.2% to 8.9% in women and from 11.1% to 12.8%
in men [19–21].
Similar results in a Polish study were obtained
by Schier, a psychologist, who evaluated 34 asth-
matics. In this study, the association of asthma
with alexithymia was non-significant [22].
Aim
The aim of the study was to assess the coexi-
stence of asthma and other disorders considered
psychosomatic in origin, to assess the impact of
stress and strong emotions on the occurrence of
acute exacerbations of asthma, to measure the le-
vel of alexithymia in asthmatic patients, and to
look for an association between the level of alexi-
thymia and acute exacerbations triggered by stress
and strong emotions.
The level of alexithymia was also assessed in
terms of asthma control.
Materials and methods
Patients with a diagnosis of asthma were en-
rolled in the study. They comprised patients in the
course of hospitalisation at the Department of
Pneumonology and Allergy, Medical University of
Warsaw, Poland, and patients reporting to the out-
patient clinic at the Independent Public Central
Teaching Hospital in Warsaw, Poland, between
November 2009 and February 2010. The study in-
volved taking the patients’ medical histories and
asking them to complete a questionnaire that inc-
luded an assessment of the level of alexithymia.
A total of 54 patients were included in the stu-
dy (75.9% were female). The mean age of the pa-
tients was 54.37 ± 14.52 years. The history inclu-
ded information on age, sex, education, occupa-
tion, age at diagnosis of asthma, and information
about any family history of asthma. The history
also included questions about co-morbidities dia-
gnosed by a doctor, in which psychological and
behavioural factors could play a role, and about co-
morbidities associated with stress, which manife-
sted as somatic disorders. These co-morbidities
were: irritable bowel disease, atopic dermatitis,
depression, panic disorder, and anorexia [7]. In the
remainder of this paper these disorders are collec-
tively referred to as ‘psychosomatic disorders’.
The second part of the study involved com-
pletion of a questionnaire. The questionnaire was
composed of three parts: a list of factors triggering
an asthma attack [23], the Asthma Control Test
(ACT), and the Toronto Alexithymia Scale
(TAS-26).
From the list of factors triggering an asthma
attack, which included: allergens present in the air,
pollutants present in the atmospheric air, respira-
tory tract infections, physical exercise, weather
changes, strong emotions, stress, foods, food addi-
tives (preservatives), drugs, tobacco smoke, and
irritants such as cleaning products, sprays, paints
and varnishes, the patients selected all those that
triggered asthma attacks in their case.
The second part of the questionnaire compri-
sed the ACT, which determines the degree of asth-
ma control. It consists of 5 questions concerning:
the frequency of symptoms, the need to use relie-
ver medication, the impact of the disease on daily
activities, and the subjective assessment of asth-
ma control. Each question is rated from 1 to 5,
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where 5 refers to good control and 1 to poor con-
trol. Total scores of 25, 20–24, and 19 or less repre-
sent fully controlled asthma, well-controlled asth-
ma, and poorly-controlled asthma, respectively [24].
The presence of alexithymia was investigated
using the TAS-26 questionnaire translated into
Polish by Maruszewski and Scigala [10]. It is one
of the questionnaire methods based on self-descrip-
tion and was developed in 1985 by Taylor and
Bagby. It contains 26 statements reflecting alexi-
thymic traits. The respondent decides whether he
or she identifies with a given trait using a scale
from 1 to 5, where 1 means “definitely disagree”
and 5 means “definitely agree”. The individual
answers are rated and a total score is calculated.
The total score ranges from 26 to 130, with a score
of more than 78 indicating alexithymia. The test
has four subscales defining: difficulty identifying
feelings and physical experiences, paucity of ima-
gination, operational thinking style, and difficul-
ty describing feelings [10].
The statistical analysis was performed using
SPSS 14.00 PL, adopting a significance level at
p<0.05. Non-parametric tests for independent sam-
ples were used to test the relationships between
qualitative variables.
Results
In the group of 54 patients with asthma, half
of the patients reported at least one disease consi-
dered psychosomatic that a doctor had diagnosed
them with. We noted 8 cases of irritable bowel syn-
drome, 7 cases of atopic dermatitis, 13 cases of de-
pression, and 9 cases of panic disorder. According
to these data, some of the patients had been diagno-
sed with more than one disorder from the list.
Alexithymia was confirmed in 11 cases
(21.6%) and stress and/or strong emotions were
demonstrated as factors triggering asthma attacks
in 33 cases (61.1%). No association was found be-
tween alexithymia and stress or strong emotions
as factors triggering asthma attacks. This associa-
tion was non-significant: c2 = 0.106, p > 0.05. No
statistically significant difference in the occurren-
ce of alexithymia between men and women was
observed: c2(1) = 1.986, p > 0.05.
The ACT results were as follows: 72.5% of the
cases showed poor asthma control, 17.6% of the
cases showed good asthma control, and 9.8% of the
cases showed complete asthma control. No asso-
ciation of the level of alexithymia with asthma
control was observed: c2(1) = 0.358, p > 0.05.
Complete or good asthma control was obse-
rved in 30.0% of women and 18.2% of men, while
poorly controlled asthma was present in 70.0% of
women and 81.8% of men. No association of sex
with asthma control was identified: c2(1) = 0.605,
p > 0.05.
Discussion
Our paper confirms the common occurrence
of alexithymia in patients with asthma and the
impact of stress and strong emotions on the occur-
rence of the disease manifestations. We also inve-
stigated the frequency of coexistence of asthma
with selected disorders considered psychosomatic
in origin and the association between asthma con-
trol and the occurrence of alexithymia.
We adopted the ICD-10 definition of asthma,
according to which, in selected cases, psychologi-
cal and behavioural factors may play the main role
in the clinical course of a somatic disorder (of the
inflammatory aetiology), such as asthma.
Our search for a relationship between asthma
and alexithymia was based on studies (including
the few Polish ones) confirming the association
Table 1. The reviev of scientific inquieries in which the coincidence of asthma and diseases known as a psychosomatic
was analised
Disease                                            Percentage of patients with alexithymia Percentage of patients Country
 with alexithymia
Total M F in the control group
Hypertension 55 – – 16 Italy [15]
Hypertension – 57 46 18 M. 9 K Finland [16]
Inflammatory bowel disease 35.7 – – 4.5 Italy [17]
Panic disorder 47–67 – – – United States of America [18]
Anorexia nervosa 68.8 – – 3.3 United Kingdom [12]
Bulimia nervosa 40–61 – – – United Kingdom [12]
M — men, F — females, – lack of data
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between these disorders and the fact that alexithy-
mia coexists with other psychosomatic disorders,
such as asthma. Our main motive while designing
this study was the general tendency to manage
patients with asthma with drug treatment only,
without offering psychological support, which se-
ems incorrect, taking into account the potential
contribution of psychological and behavioural fac-
tors. It may be that the lack of professional psy-
chological counselling leads to treatment failure.
Our results demonstrate a higher prevalence
of psychological problems in patients with asth-
ma, often in the form of alexithymia. As the syn-
drome may only be diagnosed using a specialist
questionnaire that is not widely available to do-
ctors, their task is to carefully observe the patient’s
behaviour, his or her way of responding to emo-
tions, to take a detailed history (to determine the
presence of co-morbidities that might result from
problems with regulation of emotions), and in ca-
ses that raise concerns, to consider referring the
patient to a psychologist.
In each case, diligent patient education, the
role of which in the management of asthma has
been well documented, is of extreme importance
[6]. Educational programmes generally come down
to discussing the general management and drug
treatment. Our study has shown that stress and
strong emotions trigger acute exacerbation in more
than half of the patients, which quite naturally le-
ads to increasing anxiety (and the resulting stress
and strong emotions), thereby establishing a vicio-
us circle leading to deterioration of the patient’s
condition. It is therefore essential to dispel con-
cerns and alleviate anxiety associated with the di-
sease. The very provision of information on how a
vicious circle works and, as a consequence, under-
standing of the process by the patient and learning
effective ways of coping in such situations may
facilitate disease control, which directly transla-
tes into improved quality of life [25]. It is therefo-
re important to find out what the patient’s style of
coping with stress is, as it will allow for individu-
al planning of educational activities [26].
A total of 22% of patients with asthma had an
increased level of alexithymia. For comparison, in
European populations such as German and Finnish,
elevated levels of alexithymia were observed in 8.2–
8.9% of healthy women and in 11.1–12.8% of heal-
thy men [20, 21]. Additional data on the scale of ale-
xithymia in patients with asthma in Poland could be
provided by a comparison of the study group with
the Polish population of healthy individuals.
Our results should encourage doctors to take
a wider look at the problems of each patient and
make them more sensitive to the fact that psycho-
logical problems may affect the course of the dise-
ase. This seems necessary in light of the data de-
monstrating that appropriate psychotherapy makes
it possible to reduce the level of alexithymia and
treat panic attacks, and that appropriate patient
education makes it possible to improve asthma
control [6, 27–30].
A separate task involved finding out whether
the presence of alexithymia affected asthma con-
trol (as measured by the ACT). The lack of corre-
lation between these two factors in our study se-
ems puzzling and is in contradiction with the pre-
vious studies cited in the Introduction, which de-
monstrated significantly increased levels of ale-
xithymia in patients with poorly controlled asth-
ma [18, 19]. It may result from the diversity of the
patient groups involved in the compared studies.
The correlation was positive in patients hospitali-
sed for acute exacerbation (which reflected poor
asthma control). They were compared with a gro-
up of outpatients (good asthma control) and heal-
thy individuals (control group). We evaluated asth-
ma control using the ACT only, which is a self-
description tool, rather than relying on assessments
performed by the patient’s doctor. At the same time
we would like to point out that patients often fa-
iled to understand the questions contained in the
ACT and requested assistance with interpretation
of the questions or were unable to complete the test
unaided because they found the print too small.
Due to these problems our results may not be re-
liable and should be verified against assessments
performed by doctors. The problems with the com-
pletion of the ACT emerged during the study, when
the procedure could no longer be modified. As the
ACT is a standardised tool recommended by GINA,
we believe that these problems are worth empha-
sising, as this information may be valuable to per-
sons who use it. Verification and assessment of the
ACT questions will be investigated in our next
paper.
Conclusions
The high level of alexithymia in patients with
asthma, the common presence of disorders consi-
dered psychosomatic in origin, and the large im-
pact of stress and strong emotions on the occur-
rence of acute exacerbations of asthma demonstra-
ted in our study confirm that asthma can be consi-
dered a psychosomatic disorder. Based on the fre-
quent coexistence of asthma and psychosomatic
disorders (50%) it may be concluded that these
should be taken into account while taking history
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and, in justified cases, treated by specialists. It has
been shown that psychological support is effecti-
ve in reducing alexithymia, panic disorder, and
other psychosomatic disorders [27–30] and it is a
good idea to consider involving psychologists on
hospital wards and in outpatient facilities for pa-
tients with asthma and informing patients about
the possibility to take advantage of the psycholo-
gist’s support. A clear signal of changes towards
this goal has been given by the Respiratory Dise-
ases Commission of the Polish Academy of Scien-
ces Clinical Pathophysiology Committee: “A com-
prehensive asthma management plan should inc-
lude psychotherapeutic measures, which may of-
fer an effective way of solving health problems in
patients with asthma” [31]. Such a multidiscipli-
nary approach to asthma is being tested in the
United States, where a programme to involve do-
ctors, school nurses, psychologists, and physical
education teachers has been launched to reduce the
impact of asthma on children’s lives [32].
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